Basic Information
RNALocate ID: | RLID:01002101 |
RNA Symbol: | hsa-miR-346 |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-346 |
RNA ID: | miRBase:MIMAT0000773 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22984580 |
Tissue/Cell Line: | Cell line (HEK-293) |
Method: | Next-generation RNA sequencing |
Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002100 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11002687 | Exosome | Serum | 18589210 |
RLID:11002688 | Exosome | Brain tissue | 23382797 |
RLID:11002689 | Exosome | Plasma | 23663360 |
RLID:11002690 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11001220 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
RLID-D:11003930 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-mir-346 | Medulloblastoma | MNDR-E-MI-42356 |
MNDR | hsa-miR-346 | Medulloblastoma | MNDR-E-MI-42357 |
MNDR | hsa-miR-346 | High-grade serous ovarian carcinoma | MNDR-E-MI-42358 |
MNDR | hsa-miR-346 | Lymphoma | MNDR-E-MI-42359 |
MNDR | hsa-miR-346 | Progesterone-receptor positive breast cancer | MNDR-E-MI-42360 |
MNDR | hsa-miR-346 | Her2-receptor positive breast cancer | MNDR-E-MI-42361 |
MNDR | hsa-mir-346 | Lupus nephritis | MNDR-E-MI-42362 |
MNDR | hsa-mir-346 | Melanoma and neural system tumor syndrome | MNDR-E-MI-42363 |
MNDR | hsa-mir-346 | Prostate cancer | MNDR-E-MI-42364 |
MNDR | hsa-miR-346 | Prostate cancer | MNDR-E-MI-42365 |
MNDR | hsa-miR-346 | Gastric cancer | MNDR-E-MI-42366 |
MNDR | hsa-miR-346 | Alzheimer disease | MNDR-E-MI-42367 |
MNDR | hsa-mir-346 | Sickle cell diseases | MNDR-E-MI-42368 |
MNDR | hsa-miR-346 | Dysautonomia familial | MNDR-E-MI-42369 |
MNDR | hsa-miR-346 | Seizures | MNDR-E-MI-42370 |
MNDR | hsa-miR-346 | Primary biliary cirrhosis | MNDR-E-MI-42371 |
MNDR | hsa-miR-346 | Graves disease | MNDR-E-MI-42372 |
MNDR | hsa-miR-346 | Huntington disease | MNDR-E-MI-42373 |
MNDR | hsa-miR-346 | Chorea | MNDR-E-MI-42374 |
MNDR | hsa-mir-346 | Lung cancer | MNDR-E-MI-42375 |
MNDR | hsa-miR-346 | Lung cancer | MNDR-E-MI-42376 |
MNDR | hsa-mir-346 | Parkinson disease | MNDR-E-MI-42377 |
MNDR | hsa-miR-346 | Parkinson disease | MNDR-E-MI-42378 |
MNDR | hsa-mir-346 | Breast cancer | MNDR-E-MI-42379 |
MNDR | hsa-miR-346 | Breast cancer | MNDR-E-MI-42380 |
MNDR | hsa-mir-346 | Pancreatic cancer | MNDR-E-MI-42381 |
MNDR | hsa-miR-346 | Pancreatic cancer | MNDR-E-MI-42382 |
MNDR | hsa-miR-346 | Melanoma | MNDR-E-MI-42383 |
MNDR | hsa-miR-346 | Colon cancer | MNDR-E-MI-42384 |
MNDR | hsa-miR-346 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-42385 |
MNDR | hsa-miR-346 | Familial ovarian cancer | MNDR-E-MI-42386 |
MNDR | hsa-mir-346 | Ovarian cancer | MNDR-E-MI-42387 |
MNDR | hsa-miR-346 | Invasive ductal carcinoma | MNDR-E-MI-42388 |
MNDR | hsa-miR-346 | Glioblastoma | MNDR-E-MI-42389 |
MNDR | hsa-mir-346 | Glioblastoma multiforme somatic | MNDR-E-MI-42390 |
MNDR | hsa-miR-346 | Astrocytoma | MNDR-E-MI-42391 |
MNDR | hsa-miR-346 | Malignant glioma | MNDR-E-MI-42392 |
MNDR | hsa-miR-346 | Chordoma | MNDR-E-MI-42393 |
MNDR | hsa-miR-346 | Amyotrophic lateral sclerosis | MNDR-E-MI-42394 |
MNDR | hsa-miR-346 | Osteosarcoma | MNDR-E-MI-42395 |
MNDR | hsa-miR-346 | Middle cerebral artery infarction | MNDR-E-MI-42396 |
MNDR | hsa-miR-346 | Liver cancer | MNDR-E-MI-42397 |
MNDR | hsa-mir-346 | Liver cancer | MNDR-E-MI-42398 |
MNDR | hsa-miR-346 | Uterine cancer | MNDR-E-MI-42399 |
MNDR | hsa-miR-346 | Gastric adenocarcinoma | MNDR-E-MI-42400 |
MNDR | hsa-miR-346 | Lung squamous cell carcinoma | MNDR-E-MI-42401 |
MNDR | hsa-miR-346 | Lung adenocarcinoma | MNDR-E-MI-42402 |
MNDR | hsa-mir-346 | Follicular thyroid carcinoma | MNDR-E-MI-42403 |
MNDR | hsa-miR-346 | Thyroid carcinoma | MNDR-E-MI-42404 |
MNDR | hsa-miR-346 | Ovarian carcinoma | MNDR-E-MI-42405 |
MNDR | hsa-miR-346 | Renal cell carcinoma | MNDR-E-MI-42406 |
MNDR | hsa-miR-346 | Cholangiocarcinoma | MNDR-E-MI-42407 |
MNDR | hsa-miR-346 | Esophageal cancer | MNDR-E-MI-42408 |
MNDR | hsa-mir-346 | Schizophrenia | MNDR-E-MI-42409 |
MNDR | hsa-mir-346 | Squamous cell carcinoma head and neck | MNDR-E-MI-42410 |
MNDR | hsa-miR-346 | Hepatocellular carcinoma | MNDR-E-MI-42411 |
MNDR | hsa-mir-346 | Hepatocellular carcinoma | MNDR-E-MI-42412 |
MNDR | hsa-miR-346 | Familiar ovarian carcinoma | MNDR-E-MI-42413 |
MNDR | hsa-miR-346 | B-cell lymphoma | MNDR-E-MI-42414 |
MNDR | hsa-mir-346 | Rheumatoid arthritis | MNDR-E-MI-42415 |
MNDR | hsa-miR-346 | Malignant pleural mesothelioma | MNDR-E-MI-42416 |
MNDR | hsa-miR-346 | Tonsil cancer | MNDR-E-MI-42417 |
MNDR | hsa-mir-346 | Systemic lupus erythematosus | MNDR-E-MI-42418 |
MNDR | hsa-mir-346 | Colorectal cancer | MNDR-E-MI-42419 |
MNDR | hsa-miR-346 | Colorectal cancer | MNDR-E-MI-42420 |
MNDR | hsa-mir-346 | Nasopharyngeal carcinoma | MNDR-E-MI-42421 |
MNDR | hsa-mir-346 | Nasopharynx carcinoma | MNDR-E-MI-42422 |
MNDR | hsa-mir-346 | Multiple myeloma | MNDR-E-MI-42423 |
MNDR | hsa-mir-346 | Lupus vulgaris | MNDR-E-MI-42424 |
MNDR | hsa-miR-346 | Prostatic neoplasms | MNDR-E-MI-42425 |
MNDR | hsa-miR-346 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-42426 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BCL6 | Homo sapiens | RR00220029 |
TOP